stockrowAgilent Technologies, Inc.
A Healthcare Diagnostics & Research
Agilent Technologies, Inc.’s revenue for fiscal 2025 (year ended October 2025) was $6.9 billion, up 6.73% from fiscal 2024.
- Revenue
- +8.06%
- EPS
- +8.47%
- Free cash flow
- +69.5%
- Total debt
- +8.81%
Quarter to July 2026, against a year earlier
Follow A
Alert me
Agilent Technologies, Inc. (A) Total debt
Agilent Technologies, Inc.'s total debt at the end of fiscal 2025 was $3.1B, down 8.82% from $3.3B in fiscal 2024. At the end of the quarter to 31 July 2026 it was $3.6B. Over the past ten years it has ranged from $1.7B (fiscal 2015) to $3.3B (fiscal 2024); the current reading is higher than 91% of that period. Agilent Technologies, Inc. ranks 7th of 46 Diagnostics & Research companies by total debt.
Total debt, annual
Embed this chart
Annual newest first
| Period | Total debt | Change |
|---|---|---|
| FY2025 | $3.1B | (8.82%) |
| FY2024 | $3.3B | 22.30% |
| FY2023 | $2.7B | 0.07% |
| FY2022 | $2.7B | 0.15% |
| FY2021 | $2.7B | 19.48% |
| FY2020 | $2.3B | 27.53% |
| FY2019 | $1.8B | (0.44%) |
| FY2018 | $1.8B | (0.11%) |
| FY2017 | $1.8B | (5.41%) |
| FY2016 | $1.9B | 15.05% |
Quarterly newest first
| Period | Total debt | Change |
|---|---|---|
| Jul 2026 | $3.6B | 19.47% |
| Apr 2026 | $3.1B | 0.03% |
| Jan 2026 | $3.1B | 0.00% |
| Oct 2025 | $3.1B | (8.96%) |
| 43 more quarters | Free account |
Against its own ten years
Total debt against peers
| Company | Total debt |
|---|---|
| IQV IQVIA Holdings Inc. compare | $16.1B |
| DGX Quest Diagnostics Incorporated compare | $5.6B |
| LH Labcorp Holdings Inc. compare | $5.3B |
| WAT Waters Corporation compare | $4.9B |
| A Agilent Technologies, Inc. | $3.6B |
| MTD Mettler-Toledo International, Inc. compare | $2.0B |
| ILMN Illumina, Inc. compare | $1.8B |
| IDXX IDEXX Laboratories, Inc. compare | $374.9M |
| NTRA Natera, Inc. compare | $80.3M |
What Total debt is
Total Debt tells an investor how much a company has borrowed in all, whether the money is due within a year or later.
Long Term Debt (Total) + Current Part of Debt
More on A
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement